Andres V
Division of Cardiovascular Research, St. Elizabeth's Medical Center, Boston, MA 02135, USA.
Int J Mol Med. 1998 Jul;2(1):81-9. doi: 10.3892/ijmm.2.1.81.
Abnormal proliferation of vascular smooth muscle cells (SMCs) is thought to contribute to neointimal thickening during spontaneous atherosclerosis and vessel renarrowing (restenosis) after angioplasty. This review will focus on the mechanisms underlying cell-cycle control in SMCs and its implication in atherosclerosis and restenosis. Therapeutic approaches that targeted specific cell-cycle control genes or growth regulatory molecules which effectively inhibited neointimal lesion formation will also be discussed.
血管平滑肌细胞(SMC)的异常增殖被认为会导致自发性动脉粥样硬化过程中的内膜增厚以及血管成形术后的血管再狭窄。本综述将聚焦于SMC细胞周期调控的潜在机制及其在动脉粥样硬化和再狭窄中的意义。还将讨论针对特定细胞周期调控基因或生长调节分子的治疗方法,这些方法可有效抑制内膜损伤的形成。